Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease
Phase 2
Completed
- Conditions
- Crohn's Disease
- First Posted Date
- 2011-03-16
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- Gerhard Rogler
- Target Recruit Count
- 3
- Registration Number
- NCT01316601
The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients
Terminated
- Conditions
- Crohn's Disease
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Gerhard Rogler
- Target Recruit Count
- 34
- Registration Number
- NCT01012570
Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae
Not Applicable
Terminated
- Conditions
- Crohn's Disease
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2014-12-04
- Lead Sponsor
- Gerhard Rogler
- Target Recruit Count
- 20
- Registration Number
- NCT01012726
News
No news found